These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 23042564)

  • 1. Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis.
    Armbruster CE; Mobley HL
    Nat Rev Microbiol; 2012 Nov; 10(11):743-54. PubMed ID: 23042564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteus mirabilis and Urinary Tract Infections.
    Schaffer JN; Pearson MM
    Microbiol Spectr; 2015 Oct; 3(5):. PubMed ID: 26542036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of
    Armbruster CE; Mobley HLT; Pearson MM
    EcoSal Plus; 2018 Feb; 8(1):. PubMed ID: 29424333
    [No Abstract]   [Full Text] [Related]  

  • 4. Virulence factors in Proteus bacteria from biofilm communities of catheter-associated urinary tract infections.
    Hola V; Peroutkova T; Ruzicka F
    FEMS Immunol Med Microbiol; 2012 Jul; 65(2):343-9. PubMed ID: 22533980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of Urease Activity.
    Richmond S; Yep A
    Methods Mol Biol; 2019; 2021():85-96. PubMed ID: 31309498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MrpJ Directly Regulates Proteus mirabilis Virulence Factors, Including Fimbriae and Type VI Secretion, during Urinary Tract Infection.
    Debnath I; Stringer AM; Smith SN; Bae E; Mobley HLT; Wade JT; Pearson MM
    Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30082479
    [No Abstract]   [Full Text] [Related]  

  • 7. Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility.
    Pearson MM; Sebaihia M; Churcher C; Quail MA; Seshasayee AS; Luscombe NM; Abdellah Z; Arrosmith C; Atkin B; Chillingworth T; Hauser H; Jagels K; Moule S; Mungall K; Norbertczak H; Rabbinowitsch E; Walker D; Whithead S; Thomson NR; Rather PN; Parkhill J; Mobley HL
    J Bacteriol; 2008 Jun; 190(11):4027-37. PubMed ID: 18375554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteus mirabilis Overview.
    Mobley HLT
    Methods Mol Biol; 2019; 2021():1-4. PubMed ID: 31309490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper affects virulence and diverse phenotypes of uropathogenic Proteus mirabilis.
    Huang WS; Lee YJ; Wang L; Chen HH; Chao YJ; Cheng V; Liaw SJ
    J Microbiol Immunol Infect; 2024 Jun; 57(3):385-395. PubMed ID: 38453541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From Catheter to Kidney Stone: The Uropathogenic Lifestyle of Proteus mirabilis.
    Norsworthy AN; Pearson MM
    Trends Microbiol; 2017 Apr; 25(4):304-315. PubMed ID: 28017513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Swarming and pathogenicity of Proteus mirabilis in the urinary tract.
    Mobley HL; Belas R
    Trends Microbiol; 1995 Jul; 3(7):280-4. PubMed ID: 7551643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteus mirabilis biofilms and catheter-associated urinary tract infections.
    Jacobsen SM; Shirtliff ME
    Virulence; 2011; 2(5):460-5. PubMed ID: 21921687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome Analysis of Two Strains of Proteus mirabilis with Swarming Migration Deficiency Isolated from Patients with Urinary Tract Infection.
    Peng L; Chen DQ; Jiang GM; Ou JY; Jiang Q; Zeng LT; Xiao Y; Jiang QY; Yang L; Ning Sun
    Curr Microbiol; 2020 Aug; 77(8):1381-1389. PubMed ID: 32152756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc uptake contributes to motility and provides a competitive advantage to Proteus mirabilis during experimental urinary tract infection.
    Nielubowicz GR; Smith SN; Mobley HL
    Infect Immun; 2010 Jun; 78(6):2823-33. PubMed ID: 20385754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide transposon mutagenesis of Proteus mirabilis: Essential genes, fitness factors for catheter-associated urinary tract infection, and the impact of polymicrobial infection on fitness requirements.
    Armbruster CE; Forsyth-DeOrnellas V; Johnson AO; Smith SN; Zhao L; Wu W; Mobley HLT
    PLoS Pathog; 2017 Jun; 13(6):e1006434. PubMed ID: 28614382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Urease Enzyme Production and some Other Virulence Factors Expression in Proteus mirabilis by N-Acetyl Cysteine and Dipropyl Disulphide.
    Abdel-Baky RM; Ali MA; Abuo-Rahma GEAA; AbdelAziz N
    Adv Exp Med Biol; 2017; 973():99-113. PubMed ID: 28190143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and mutation of a luxS-encoded autoinducer in Proteus mirabilis.
    Schneider R; Lockatell CV; Johnson D; Belas R
    Microbiology (Reading); 2002 Mar; 148(Pt 3):773-782. PubMed ID: 11882712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of polyphosphate kinase in virulence and stress tolerance of uropathogenic Proteus mirabilis.
    Peng L; Jiang Q; Pan JY; Deng C; Yu JY; Wu XM; Huang SH; Deng XY
    Med Microbiol Immunol; 2016 Apr; 205(2):97-109. PubMed ID: 26233310
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Pawar S; Ashraf MI; Mujawar S; Mishra R; Lahiri C
    Front Cell Infect Microbiol; 2018; 8():269. PubMed ID: 30131943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptome of Proteus mirabilis in the murine urinary tract: virulence and nitrogen assimilation gene expression.
    Pearson MM; Yep A; Smith SN; Mobley HL
    Infect Immun; 2011 Jul; 79(7):2619-31. PubMed ID: 21505083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.